Clinical Trials Browser

Active not recruiting × tislelizumab × Endocrine × Clear all

NCT05167071 2025-04-27

HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study

Phase 1 Active not recruiting

Neuroendocrine Tumors